Back to search results
NCT06182241

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

Active, Not Recruiting
NAAges 18+InterventionalTreatment
Boston University Charles River Campus
~80 participants
Updated 2026-07-27 on ClinicalTrials.gov
What's tested:Retention in cervical cancer care intervention

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of the intervention
Measured over About 1 month after the start of intervention and at about 3 months after the start of the intervention
+1 more outcome measured

Conditions

Cervical Cancer
Hiv

Explore related trials

Cervical CarcinomaHIV Infection

Where it's being run

3 sites across 2 states
Massachusetts2
KwaZulu-Natal1

Study leadership

  • Amelia Stanton, PhD · PRINCIPAL_INVESTIGATOR · Boston University Charles River Campus

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Having a cervix
Aged 18+
Living with HIV
Recent high-risk abnormal Pap results within the last month (if needed, we may increase the range by up to 6 months to ensure that we meet our targets).
Having a cervix
Aged 18+
Living with HIV
Recent Pap smear test (within the past two months).

Exclusion

Younger than 18 years old
HIV-negative
No cervix/history of hysterectomy
Recent normal or low-risk abnormal Pap results
Unable to provide informed consent or assent in English or isiZulu and/or have a significant psychiatric illness (e.g., active psychotic disorder or untreated bipolar disorder) that could interfere with participation will be excluded. Potential participants will also be asked if they have any health conditions that make it difficult for them to travel to the clinic.
Younger than 18 years old
HIV-negative
No cervix/history of hysterectomy
Unable to provide informed consent in English or isiZulu and/or have a significant psychiatric illness (e.g., active psychotic disorder or untreated bipolar disorder) that could interfere with participation will be excluded. Potential participants will also be asked if they have any health conditions that make it difficult for them to travel to the clinic.

What this trial measures

  • Feasibility of the interventionAbout 1 month after the start of intervention and at about 3 months after the start of the intervention

    Feasibility will be demonstrated if all three are met by participants: (1) 50% of participants who are approached choose to enroll; (2) 70% of participants complete the intervention; and (3) 60% complete the 3-month follow-up. Feasibility of the implementation of the intervention will be explored in interviews with providers and clinic staff. To assess fidelity, each intervention session with be audio recorded; an assessor will review 20% of the session transcripts and determine whether all key session themes were addressed using checklists developed by the study team for the intervention.

  • Acceptability of the interventionAbout 1 month after the start of intervention and at about 3 months after the start of the intervention

    Acceptability will be measured using the seven component constructs of the acceptability of health care interventions framework using a five-point Likert style scale. The seven components include affective attitude (i.e., how an individual feels about the intervention), burden, ethicality (i.e., the extent to which the intervention aligns with one's value system), intervention coherence, opportunity costs, perceived effectiveness, and self-efficacy. Acceptability will be demonstrated if, on average, at least 75% of the participants rate five or more of the items on the eight-item Acceptability of Healthcare Interventions Questionnaire with a 4 or a 5 on the Likert-style scale. Acceptability of the intervention will also be explored in interviews with providers, clinic staff, interventionalists, and other relevant stakeholders.